DK0540099T3 - Vandopløselige camptothecinderivater - Google Patents

Vandopløselige camptothecinderivater

Info

Publication number
DK0540099T3
DK0540099T3 DK92203263.6T DK92203263T DK0540099T3 DK 0540099 T3 DK0540099 T3 DK 0540099T3 DK 92203263 T DK92203263 T DK 92203263T DK 0540099 T3 DK0540099 T3 DK 0540099T3
Authority
DK
Denmark
Prior art keywords
water
camptothecin derivatives
soluble camptothecin
soluble
derivatives
Prior art date
Application number
DK92203263.6T
Other languages
English (en)
Inventor
Jeffrey M Besterman
Michael Joseph Luzzio
Michael G Evans
Peter Leslie Myers
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of DK0540099T3 publication Critical patent/DK0540099T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
DK92203263.6T 1991-10-29 1992-10-23 Vandopløselige camptothecinderivater DK0540099T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78427591A 1991-10-29 1991-10-29
US82672992A 1992-01-28 1992-01-28

Publications (1)

Publication Number Publication Date
DK0540099T3 true DK0540099T3 (da) 1996-06-17

Family

ID=27120258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92203263.6T DK0540099T3 (da) 1991-10-29 1992-10-23 Vandopløselige camptothecinderivater

Country Status (25)

Country Link
EP (1) EP0540099B1 (da)
JP (2) JP3020760B2 (da)
KR (1) KR100246154B1 (da)
CN (1) CN1072683A (da)
AP (1) AP306A (da)
AT (1) ATE136898T1 (da)
AU (1) AU657007B2 (da)
CA (1) CA2081580A1 (da)
CZ (1) CZ284023B6 (da)
DE (1) DE69209969T2 (da)
DK (1) DK0540099T3 (da)
ES (1) ES2086643T3 (da)
FI (3) FI104373B (da)
GR (1) GR3020120T3 (da)
HU (2) HU217970B (da)
IL (1) IL103571A (da)
IS (1) IS1708B (da)
MX (1) MX9206211A (da)
MY (1) MY108261A (da)
NO (1) NO302073B1 (da)
NZ (1) NZ244914A (da)
OA (1) OA09767A (da)
RU (1) RU2119921C1 (da)
SK (1) SK323792A3 (da)
TW (1) TW221994B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364858A (en) * 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
JP3099128B2 (ja) * 1993-01-15 2000-10-16 ザ ステーリン ファウンデーション フォー キャンサー リサーチ 閉ラクトン環形態の水不溶性ｓ−カンプトテシンを用いる癌の経皮的治療
US5369127A (en) * 1993-04-21 1994-11-29 Allergan, Inc. 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
IS4152A (is) * 1993-04-29 1994-10-30 Glaxo Inc. Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
AU684777B2 (en) * 1993-05-03 1998-01-08 Smithkline Beecham Corporation Substituted methylenedioxy(3',4':6,7)indolizino-(1,2-b)quinolinones
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5491237A (en) * 1994-05-03 1996-02-13 Glaxo Wellcome Inc. Intermediates in pharmaceutical camptothecin preparation
IT1269862B (it) * 1994-05-30 1997-04-15 Indena Spa Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
KR960029336A (ko) 1995-01-09 1996-08-17 김충환 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
US5496952A (en) * 1995-02-07 1996-03-05 North Carolina State University Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5670500A (en) * 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
EP0837850B1 (en) * 1995-06-27 2004-09-01 Takeda Chemical Industries, Ltd. 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
SG88737A1 (en) * 1996-10-30 2002-05-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) * 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
EE200200471A (et) 2000-02-28 2003-12-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6548488B2 (en) 2000-03-17 2003-04-15 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US6486320B2 (en) 2000-09-15 2002-11-26 Aventis Pharma S.A. Preparation of camptothecin and of its derivatives
EE200300184A (et) 2000-10-27 2003-08-15 Aventis Pharma S.A. Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini kombinatsioonis stilbeeni derivaadiga, ning selle kasutamine vähktõve raviks
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
WO2006069344A2 (en) 2004-12-22 2006-06-29 Rutgers, The State University Of New Jersey Controlled release hydrogels
WO2012050591A1 (en) 2010-10-15 2012-04-19 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery
JP5313867B2 (ja) 2006-03-30 2013-10-09 ドライス ファーマシューティカルズ，インコーポレイティド カンプトテシン−細胞透過性ペプチド複合体及びそれを含む医薬組成物
CN101407524B (zh) * 2007-10-09 2012-07-18 江苏先声药物研究有限公司 噁嗪骈喜树碱衍生物及其制备方法和用途
CN100592871C (zh) * 2008-03-14 2010-03-03 浙江林学院 一种杀虫剂组合物及其加工方法
ES2373172B1 (es) * 2010-07-16 2012-12-10 Consejo Superior De Investigaciones Científicas (Csic) Proceso de obtención de derivados solubles en agua de 20 (s) camptotecina como agentes antitumorales.
US8980909B2 (en) 2011-01-12 2015-03-17 Crystal Biopharmaceutical Llc HDAC inhibiting derivatives of camptothecin
JP7430643B2 (ja) * 2018-04-06 2024-02-13 シージェン インコーポレイテッド カンプトテシンペプチドコンジュゲート
CN110590796B (zh) * 2018-06-12 2022-07-15 青岛海洋生物医药研究院股份有限公司 喜树碱衍生物及其制备方法和应用
CN117769555A (zh) * 2021-08-19 2024-03-26 先声再明医药有限公司 喜树碱衍生物、其药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

Also Published As

Publication number Publication date
FI924878A (fi) 1993-04-30
IL103571A0 (en) 1993-03-15
SK279298B6 (sk) 1998-09-09
NO924158L (no) 1993-04-30
CZ323792A3 (en) 1993-10-13
DE69209969D1 (de) 1996-05-23
SK323792A3 (en) 1998-09-09
HU217970B (hu) 2000-05-28
FI982185A0 (fi) 1998-10-08
FI982185A (fi) 1998-10-08
EP0540099A1 (en) 1993-05-05
KR100246154B1 (ko) 2000-04-01
JP3229298B2 (ja) 2001-11-19
HUT65719A (en) 1994-07-28
NO302073B1 (no) 1998-01-19
ATE136898T1 (de) 1996-05-15
AP9200439A0 (en) 1992-10-31
DE69209969T2 (de) 1996-09-12
IL103571A (en) 1998-01-04
AU657007B2 (en) 1995-02-23
GR3020120T3 (en) 1996-08-31
JPH05222048A (ja) 1993-08-31
JP3020760B2 (ja) 2000-03-15
AU2738592A (en) 1993-05-06
FI20021090A (fi) 2002-06-07
RU2119921C1 (ru) 1998-10-10
EP0540099B1 (en) 1996-04-17
MY108261A (en) 1996-09-30
AP306A (en) 1994-01-28
FI104373B (fi) 2000-01-14
IS1708B (is) 1998-12-16
JP2000109475A (ja) 2000-04-18
IS3936A (is) 1993-04-30
CN1072683A (zh) 1993-06-02
HU211349A9 (en) 1995-11-28
MX9206211A (es) 1993-05-01
OA09767A (en) 1993-11-30
HU9203384D0 (en) 1993-01-28
CA2081580A1 (en) 1993-04-30
NZ244914A (en) 1995-01-27
FI924878A0 (fi) 1992-10-28
CZ284023B6 (cs) 1998-07-15
ES2086643T3 (es) 1996-07-01
NO924158D0 (no) 1992-10-28
TW221994B (da) 1994-04-01

Similar Documents

Publication Publication Date Title
DK0540099T3 (da) Vandopløselige camptothecinderivater
DE69208877T2 (de) Chinuclidinderivate
NO923618D0 (no) Benzanilid-derivater
NO923617L (no) Benzanilid-derivater
NO922182D0 (no) Krystallinske oksatiolan-derivater
DE69119329D1 (de) Actinonin-Derivate
FI925523A0 (fi) Hydroxi- och alkoxipyridinderivat
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
DE69125099T2 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
ATE171449T1 (de) Oxadolderivate
DK0472733T3 (da) Phenantrenderivater
DK81989A (da) Substituerede quinolinderivater
DK82189A (da) Substituerede quinolinderivater
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
DE69119323T2 (de) Fluoräthylcamptothecinderivate
DE9290049U1 (de) 4-Aryl-3-(heteroarylureido)chinolin-Derivate
MX9206710A (es) Derivados de piridinol
DE69211197D1 (de) 1-Hydroxyvitamin D-Derivate
DK82089A (da) Substituerede quinolinderivater
KR930702353A (ko) 2- 카르바페넴 유도체
DE69227554T2 (de) Indolinospirobenzopyran-derivate
DK0491053T3 (da) Vandopløselige bis-dioxopiperazinderivater med antitumoregenskaber
BR1100452A (pt) Derivados do bifenilmetilimidazol
DK81588A (da) Gametocide n-phosphonomethylglycinderivater